Fonar - 25 Year Stock Price History | FONR

Historical daily share price chart and data for Fonar since 1993 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Fonar as of November 16, 2018 is 22.10.
Fonar Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 25.9251 24.3500 29.8000 21.8000 22.1000 -9.24%
2017 24.4442 19.2250 33.6000 17.4500 24.3500 27.15%
2016 18.1649 16.7800 23.7800 13.3200 19.1500 10.95%
2015 12.5383 10.2600 18.3300 9.1300 17.2600 65.96%
2014 14.4647 20.1700 26.3200 9.6700 10.4000 -50.96%
2013 8.0377 4.6000 21.2080 4.5900 21.2080 389.79%
2012 3.6961 1.7300 6.4000 1.6900 4.3300 154.11%
2011 1.8012 1.3000 2.6500 1.2600 1.7040 31.08%
2010 1.4940 1.7000 2.7200 1.0200 1.3000 -17.20%
2009 1.6153 0.9200 3.1900 0.6305 1.5700 89.16%
2008 2.4096 5.3200 5.3200 0.6651 0.8300 -84.04%
2007 6.4569 7.5000 8.1400 4.2080 5.2000 -25.71%
2006 12.2490 17.7500 20.5000 6.2500 7.0000 -58.82%
2005 29.9603 39.2500 43.0000 17.0000 17.0000 -56.69%
2004 32.0387 29.0000 42.7500 25.5000 39.2500 36.52%
2003 30.8125 26.7500 49.5000 20.2500 28.7500 7.48%
2002 30.6647 30.5000 50.2500 24.2500 26.7500 -10.08%
2001 37.9819 32.7500 62.2500 25.7500 29.7500 -9.16%
2000 57.9931 46.7500 112.5000 28.0000 32.7500 -22.49%
1999 31.2716 35.0538 75.0000 18.7500 42.2500 35.96%
1998 50.5701 68.5234 73.8883 26.1990 31.0761 -56.65%
1997 69.5490 54.8675 96.8107 52.6728 71.6936 25.64%
1996 60.0365 64.8656 73.8883 51.6974 57.0622 -12.03%
1995 66.3674 46.5764 97.5423 40.4800 64.8656 33.00%
1994 42.2809 52.6728 62.4270 30.4820 48.7711 -7.41%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.141B $0.082B
FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.543B 19.40
Abbott Laboratories (ABT) United States $126.526B 25.64
Stryker (SYK) United States $64.420B 24.28
Boston Scientific (BSX) United States $51.491B 26.02
Baxter (BAX) United States $35.393B 22.86
Zimmer Biomet Holdings (ZBH) United States $23.875B 15.48
Smith & Nephew SNATS (SNN) United Kingdom $16.038B 0.00
ResMed (RMD) United States $14.846B 28.31
Perrigo (PRGO) Ireland $8.596B 13.05
Bio-Rad Laboratories (BIO) United States $8.274B 52.91
Canopy Growth (CGC) Canada $8.174B 0.00
Hill-Rom Holdings (HRC) United States $6.270B 19.88
Aurora Cannabis (ACB) Canada $6.172B 33.68
Haemonetics (HAE) United States $5.727B 50.36
ICU Medical (ICUI) United States $4.968B 27.68
Insulet (PODD) United States $4.838B 0.00
Agios Pharmaceuticals (AGIO) United States $4.052B 0.00
Hutchison China MediTech (HCM) China $4.010B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.990B 0.00
Neogen (NEOG) United States $3.294B 49.88
NuVasive (NUVA) United States $3.166B 29.46
National Vision Holdings (EYE) United States $3.024B 58.49
Quidel (QDEL) United States $2.507B 32.68
Aphria (APHA) $2.433B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.409B 19.95
AtriCure (ATRC) United States $1.241B 0.00
Cardiovascular Systems (CSII) United States $1.058B 1524.50
VAREX IMAGING (VREX) United States $0.999B 20.07
Meridian Bioscience (VIVO) United States $0.823B 26.23
Surmodics (SRDX) United States $0.794B 121.41
OraSure Technologies (OSUR) United States $0.772B 43.48
Eagle Pharmaceuticals (EGRX) United States $0.756B 24.24
MacroGenics (MGNX) United States $0.740B 0.00
Cerus (CERS) United States $0.716B 0.00
PetIQ (PETQ) United States $0.705B 20.03
Lantheus Holdings (LNTH) United States $0.625B 19.34
Omeros (OMER) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.540B 26.52
Owens & Minor (OMI) United States $0.535B 6.05
Insys Therapeutics (INSY) United States $0.527B 0.00
NanoString Technologies (NSTG) United States $0.521B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.403B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.45
Cytosorbents (CTSO) United States $0.313B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.264B 0.00
Surface Oncology (SURF) United States $0.225B 0.00
Rockwell Medical (RMTI) United States $0.214B 0.00
BioLife Solutions (BLFS) United States $0.204B 275.00
Chimerix (CMRX) United States $0.172B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.146B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 21.07
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00